Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02408315 · ClinicalTrials.gov registry record · Phase 3
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
A Phase 3 study of Pregnancy, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT02408315 is a Phase 3 study of Pregnancy that has completed, run by Indiana University. The registered enrollment target is 300 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02408315, a Phase 3 study of Pregnancy, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to compare the efficacy and safety of vaginal and buccal misoprostol for women undergoing labor induction at greater than or equal to 37+ 0 completed weeks gestation. Thus, the investigators have both efficacy and a safety primary outcomes. The secondary objective of this study is to assess the pharmacokinetic(PK) parameters with these two routes of administration in a sub-cohort of this trial. The long term objective of this line of research is to inform providers' clinical decision making for the large number of women having labor induction. By providing robust PK and pharmacodynamic (PD) evaluation, clinical outcomes data for these two routes of administration, clinicians will be informed for evidence-based decisions about the preferred route of administration of misoprostol.
Conditions Studied
Interventions
- DRUG misoprostol/placebo
Study Locations (2)
Indiana
- IU Health Methodist Hospital - Indianapolis
- Sidney and Lois Eskenazi Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2015-09 |
| Est. Completion | 2021-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02408315
The ClinicalTrials.gov registry entry for NCT02408315 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (66% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which misoprostol/placebo is the first listed.
NCT02408315 reports 2 study locations spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT02408315 about?
NCT02408315 is a clinical study titled "Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)". The primary objective of this study is to compare the efficacy and safety of vaginal and buccal misoprostol for women undergoing labor induction at greater than or equal to 37+ 0 completed weeks gestation. Thus, the investigators have both efficacy and a safety primary outcomes. The secondary objec...
What is the current status of trial NCT02408315?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2015-09. Estimated completion is 2021-12.
What conditions does trial NCT02408315 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT02408315?
The interventions under investigation include: misoprostol/placebo (DRUG).
Who is sponsoring clinical trial NCT02408315?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02408315 being conducted?
This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Different Medications to Induce Labor
RECRUITING · Phase 3
-
Ropivacaine and Fentanyl for Labor Epidural Initiation
RECRUITING · Phase 3
-
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
RECRUITING · Phase 3
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
COMPLETED · Phase 3
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
COMPLETED · Phase 3
-
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.